Vimarsana
Biggest News Aggregation in the World

Page 2 - Scott Lim News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scott Lim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scott Lim Today - Breaking & Trending Today

'Major Milestone' as Israeli Heart Valve Implanted in First US Patients - Vimarsana News

'Major Milestone' as Israeli Heart Valve Implanted in First US Patients

To date, the valve has been implanted in ten human subjects, five of whom were part of an Israeli pilot study.

Melanoma battle didn't stop Erie firefighter - Vimarsana News

Melanoma battle didn't stop Erie firefighter

Melanoma is the deadliest type of skin cancer. Nearly 8,000 Americans are expected to die from melanoma in 2023.

Source: goerie.com
EDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE - Vimarsana News

EDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE

/PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its technology...

PASCAL transcatheter valve repair system as good as MitraClip in patients with significant symptomatic DMR Not Eligible for Surgery: CLASP IID trial - Vimarsana News

PASCAL transcatheter valve repair system as good as MitraClip in patients with significant symptomatic DMR Not Eligible for Surgery: CLASP IID trial

According to a new randomized controlled trial PASCALtranscatheter valve repair system was non-inferior compared with MitraClip in patients with significant symptomatic DMR who are not eligible for...

Novel TEER Repair Device Meets Primary Endpoint in Treating Degenerative Mitral Regurgitation in Patients Not Eligible for Surgery - Vimarsana News

Novel TEER Repair Device Meets Primary Endpoint in Treating Degenerative Mitral Regurgitation in Patients Not Eligible for Surgery

Results of the CLASP IID Trial Presented at TCT and published simultaneously in JACC: Cardiovascular InterventionsÂ